Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SCN4A | P35499 | 7/20 | 0.50 |
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43945 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL170928 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL29503095 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| Benzene SCHEMBL28170835 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL28382272 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Iodide SCHEMBL6672339 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL7185884 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL5945406 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL6852974 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL1607928 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120152488-A | Self-driven X-ray detector based on metal cation doped chiral perovskite and preparation method thereof | 郑州大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119923169-A | Method for improving circularly polarized light detection performance of perovskite film through achiral cations | 复旦大学 | 2025-05-02 | — | — | CN | claimed |
| CN-119899184-A | Beta-carboline compound, preparation method thereof and application thereof in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2025-04-29 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-20250078176-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2025-03-06 | — | — | US | claimed |
| CN-118946165-A | Interface interaction spin-photon conversion body heterostructure and preparation method | 武汉大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118922037-A | Chiral photoelectric functional material with wide band gap and preparation method thereof | 武汉大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118745344-A | Perovskite circular polarization luminescent material with chiral low-dimensional-three-dimensional heterojunction structure and application thereof | 武汉大学 | 2024-10-08 | — | — | CN | claimed |
| CN-118435582-A | Environmental attributes of nitrogen-containing chemicals | 巴斯夫欧洲公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117820204-A | Preparation method of R-3-benzyl-3-piperidine formyl trimethylhydrazine | 山东百诺医药股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-1819330-A1 | 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY | Devgen N.V. (BE) | 2007-08-22 | — | — | EP | claimed |
| US-20070123578-A1 | Hexahydro-cycloheptapyrazole cannabinoid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-31 | — | — | US | claimed |
| US-7166628-B2 | Cytokine inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2007-01-23 | — | — | US | claimed |
| EP-1741697-A1 | CRYSTAL COMPRISING (2R)-2-PROPYLOCTOIC ACID AND AMINE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-10 | — | — | EP | claimed |
| WO-2006066879-A2 | COMPOUNDS WITH KV4 ION CHANNEL ACTIVITY | DEVGEN N.V. (BE) | 2006-06-29 | — | — | WO | claimed |
| EP-1567507-B1 | 1,2,3- TRIAZOLE AMIDE DERIVATIVES AS CYTOKINE INHIBITORS | BOEHRINGER INGELHEIM PHARMA (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2006058905-A1 | 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY | DEVGEN NV (BE) | 2006-06-08 | — | — | WO | claimed |
| EP-1567507-A1 | 1,2,3- TRIAZOLE AMIDE DERIVATIVES AS CYTOKINE INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-08-31 | — | — | EP | claimed |
| WO-2004050642-A1 | 1, 2, 3- TRIAZOLE AMIDE DERIVATIVES AS CYTOKINE INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-06-17 | — | — | WO | claimed |
| US-20040102492-A1 | Cytokine inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102492-A1 | Cytokine inhibitors | IL1A, IL1B, IL1RN | SLC6A4 4772/4885LMNA 4141/4885SCN4A 2838/4885 |
| US-20070123578-A1 | Hexahydro-cycloheptapyrazole cannabinoid modulators | CNR2, CNR1, FAAH | SLC6A4 438/4885LMNA 4644/4885SCN4A 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.